Quantbot Technologies’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,948
Closed -$93.2K 2179
2025
Q3
$93.2K Buy
+1,948
New +$54K ﹤0.01% 1441

Quantbot Technologies's TRML Position: Q4 2025 in Review

Quantbot Technologies sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,948 shares — an estimated $93.2K sold.

Quantbot Technologies first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $93.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Quantbot Technologies reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 1,948 Tourmaline Bio shares in Q4 2025, an estimated $93.2K.
  • Quantbot Technologies first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Quantbot Technologies's Tourmaline Bio position peaked at $93.2K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.